SCHEMBL7727701

SCHEMBL7727701

CC(C)(C)OC(=O)N1CC(OC=O)C[C@H]1C(=O)Nc1ccc(Oc2ccccc2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.46
MEN1 O00255 2/20 0.46
KMT2A Q03164 2/20 0.46
HDAC8 Q9BY41 3/20 0.44
ALDH1A1 P00352 1/20 0.43
MAPK1 P28482 1/20 0.43
HTT P42858 1/20 0.43
RECQL P46063 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
MCL1 Q07820 4/20 0.43
CYP3A4 P08684 2/20 0.42
CYP1A2 P05177 1/20 0.42
POLB P06746 1/20 0.42
CYP2C19 P33261 1/20 0.42
S1PR1 P21453 2/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
PABPC1 P11940 1/20 0.41
PDK1 Q15118 1/20 0.41
PDK2 Q15119 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7727705 1.00 NPC1 (0.46) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7729361 0.86 SMN1; SMN2 (0.49) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7729359 0.86 SMN1; SMN2 (0.49) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7728024 0.85 MEN1 (0.62) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7728781 0.85 MEN1 (0.62) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7728020 0.85 MEN1 (0.62) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7728568 0.84 MEN1 (0.51) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7728565 0.84 MEN1 (0.51) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7722275 0.79 HDAC8 (0.42) NPC1MEN1KMT2AHDAC8ALDH1A1
SCHEMBL7722273 0.79 NAMPT (0.47) NPC1MEN1KMT2AHDAC8ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6399629-B1 PYRROLIDINES AND PIPERIDINES FOR TREATING MICROBIAL INFECTIONS BY REDUCING EXPORT OF COADMINISTERED ANTIMICROBIAL AGENT OR COMPOUND SYNTHESIZED BY MICROBES FOR THEIR GROWTH; REDUCING IN VIVO AVAILABILITY MICROCIDE PHARMACEUTICALS, INC. 2002-06-04 US disclosed
WO-2000001714-A1 EFFLUX PUMP INHIBITORS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-01-13 WO disclosed